Loading clinical trials...
Loading clinical trials...
This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.
Misoprostol is the primary drug of choice for medical termination. It is not only cheap, but also stable at room temperature and easily available worldwide. It is indicated for the treatment of gastritis, but is widely used off-label for a variety of indications in the practice of obstetrics and gynecology, including medication abortion, induction of labor, and the treatment of postpartum hemorrhage. The optimal dosage and route of administration have not been well defined and vary with physicians. The potency of misoprostol's effect varies with dosage, route of administration and dosing interval; both maternal and fetal factors may, to certain extent, affect the abortion interval. This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.
Age
13 - 50 years
Sex
FEMALE
Healthy Volunteers
No
Far Eastern Memorial Hospital
New Taipei, Taiwan, Taiwan
Start Date
August 1, 2013
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2014
Last Updated
July 7, 2015
101
ACTUAL participants
Lead Sponsor
Far Eastern Memorial Hospital
NCT04075630
NCT05257187
NCT05827731
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions